Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;51(1):29-30.
doi: 10.1007/s11239-020-02200-w.

Pharmacologic therapeutic options for thromboprophylaxis in COVID-19

Chia Siang Kow  1 , Syed Shahzad Hasan  2
Affiliations

Pharmacologic therapeutic options for thromboprophylaxis in COVID-19

Chia Siang Kow et al. J Thromb Thrombolysis. 2021 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

References

    1. Gris JC, Perez-Martin A, Quéré I, Sotto A. COVID-19 associated coagulopathy: the crowning glory of thrombo-inflammation concept. Anaesth Crit Care Pain Med. 2020 doi: 10.1016/j.accpm.2020.04.013. - DOI - PMC - PubMed
    1. Middeldorp S, Coppens M, van Haaps TF, Foppen M, Vlaar AP, Müller MCA, Bouman CCS, Beenen LFM, Kootte RS, Heijmans J, Smits LP, Bonta PI, van Es N. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020 doi: 10.1111/jth.14888. - DOI - PMC - PubMed
    1. Artifoni M, Danic G, Gautier G, et al. Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors. J Thromb Thrombolysis. 2020 doi: 10.1007/s11239-020-02146-z. - DOI - PMC - PubMed
    1. Gibson CM, Halaby R, Korjian S, Daaboul Y, Arbetter DF, Yee MK, Goldhaber SZ, Hull R, Hernandez AF, Lu SP, Bandman O, Leeds JM, Gold A, Harrington RA, Cohen AT, APEX Investigators The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial. Am Heart J. 2017;185:93–100. doi: 10.1016/j.ahj.2016.12.004. - DOI - PubMed
    1. Cohoon KP, De Sanctis Y, Haskell L, McBane RD, Spiro TE. Rivaroxaban for thromboprophylaxis among patients recently hospitalized for acute infectious diseases: a subgroup analysis of the MAGELLAN study. J Thromb Haemost. 2018;16(7):1278–1287. doi: 10.1111/jth.14146. - DOI - PubMed

MeSH terms